| 1. The study of association between iNKT cells in recipient with aGVHD after allogeneic HSCT.” |
| 2. The study of correlation between regulatory T cells in PBSC grafts with aGVHD after allogeneic HSCT in patients with blood malignancy referred to taleghani hospital in 2016.” |
| 3. The study of association between soluble CD226 levels with aGvHD after allogeneic HSCT |
| 4. Study of association between CD4+/CD8+ count with aGVHD after allogenic hematopoietic SCT in patients with blood malignancy |
| 5. Evaluation of ST2 as a biomarker for aGvHD |
| 6. Evaluation of Elafin as a prognostic biomarker for skin aGVHD |
| 7. Evaluation of tim-3 as a biomarker for GI-GVHD |
| 8. evaluation of CCL8 and CXCL10 as biomarkers of aGVHD.” |
| 9. Evaluation of viral PCR positivity in stool before allogenic HSCT as a predictor marker for aGI-GVHD. |
| 10. Evaluation of 3-IS as an affordable and quick marker for prediction of microbiota disruption in GI-GvHD |
| 11. Evaluation of Reg3-alpha as a discriminator marker between GVHD and non GVHD causes of diarrhea |
| 12. Evaluation of Intestinal Blautia as predictive factor of GI-GVHD |
| 13. Evaluation of TH1/TH2 ratio in donor and recipient as a prognostic factor of GVHD after allo HSCT |
| 14. Evaluation of serum profile of cytokines as potential biomarkers for prediction/prognosis of acute GVHD following allogeneic HSCT |
| 15. Evaluation of homing molecules, CLA and CCR4 and CCR10 as a prognostic biomarker of acute GvHD in patients referring to BMT center of Taleghani Hospital in 2016 |